Clinical Trial Update: Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. [Phase 3]

View source ↗

Summary

The Phase 3 clinical trial of DCVax-Prostate for prostate cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DCVax-Prostate (DCVax-Prostate)

Snippet

Sponsor: Northwest Biotherapeutics | Conditions: Prostate Cancer | Phase 3 | Status: WITHDRAWN